Stay updated on Faricimab in Neovascular AMD Clinical Trial
Sign up to get notified when there's something new on the Faricimab in Neovascular AMD Clinical Trial page.

Latest updates to the Faricimab in Neovascular AMD Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedPublications section updated with a new 2026 JAMA Ophthalmol. article and removal of the previously listed online-ahead-of-print version.SummaryDifference0.0%

- Check24 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check39 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check46 days agoChange Detected- Added Publication citation: Pitcher JD 3rd, Koh AHC, Tan CS, Vakharia P, Dagincourt N, Patel S, Yang M, Margaron P, Gallego-Pinazo R. Rapid Fluid Resolution and Durability With Faricimab in Neovascular Age-Related Macular Degeneration. JAMA Ophthalmol. 2026 Feb 19:e256365. Online ahead of print.SummaryDifference0.0%

- Check60 days agoChange DetectedMinor internal revision from v3.4.1 to v3.4.2 with no user-facing changes to study content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check68 days agoChange DetectedThe page shows a site revision from v3.4.0 to v3.4.1. No changes to study content, eligibility criteria, or results are visible.SummaryDifference0.0%

Stay in the know with updates to Faricimab in Neovascular AMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Faricimab in Neovascular AMD Clinical Trial page.